Literature DB >> 30633767

A proteome-wide screen of Campylobacter jejuni using protein microarrays identifies novel and conformational antigens.

Jiayou Liu1, Jodi R Parrish1, Julie Hines1, Linda Mansfield2, Russell L Finley1,3.   

Abstract

Campylobacter jejuni (C. jejuni) is a foodborne intestinal pathogen and major cause of gastroenteritis worldwide. C. jejuni proteins that are immunogenic have been sought for their potential use in the development of biomarkers, diagnostic assays, or subunit vaccines for humans or livestock. To identify new immunogenic C. jejuni proteins, we used a native protein microarray approach. A protein chip, with over 1400 individually purified GST-tagged C. jejuni proteins, representing over 86% of the proteome, was constructed to screen for antibody titers present in test sera raised against whole C. jejuni cells. Dual detection of GST signals was incorporated as a way of normalizing the variation of protein concentrations contributing to the antibody staining intensities. We detected strong signals to 102 C. jejuni antigens. In addition to antigens recognized by antiserum raised against C. jejuni, parallel experiments were conducted to identify antigens cross-reactive to antiserum raised against various serotypes of E. coli or Salmonella or to healthy human sera. This led to the identification of 34 antigens specifically recognized by the C. jejuni antiserum, only four of which were previously known. The chip approach also allowed identification of conformational antigens. We demonstrate in the case of Cj1621 that antigen signals are lost to denaturing conditions commonly used in other approaches to identify immunogens. Antigens identified in this study include those possessing sequence features indicative of cell surface localization, as well as those that do not. Together, our results indicate that the unbiased chip-based screen can help reveal the full repertoire of host antibodies against microbial proteomes.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30633767      PMCID: PMC6329530          DOI: 10.1371/journal.pone.0210351

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  51 in total

1.  Printing proteins as microarrays for high-throughput function determination.

Authors:  G MacBeath; S L Schreiber
Journal:  Science       Date:  2000-09-08       Impact factor: 47.728

2.  Antibody microarray profiling of human prostate cancer sera: antibody screening and identification of potential biomarkers.

Authors:  Jeremy C Miller; Heping Zhou; Joshua Kwekel; Robert Cavallo; Jocelyn Burke; E Brian Butler; Bin S Teh; Brian B Haab
Journal:  Proteomics       Date:  2003-01       Impact factor: 3.984

3.  Tumor-suppressive maspin regulates cell response to oxidative stress by direct interaction with glutathione S-transferase.

Authors:  Shuping Yin; Xiaohua Li; Yonghong Meng; Russell L Finley; Wael Sakr; Heng Yang; Neelima Reddy; Shijie Sheng
Journal:  J Biol Chem       Date:  2005-07-26       Impact factor: 5.157

4.  Identification of immunogenic and virulence-associated Campylobacter jejuni proteins.

Authors:  Lene N Nielsen; Thomas A Luijkx; Christina S Vegge; Christina Kofoed Johnsen; Piet Nuijten; Brendan W Wren; Hanne Ingmer; Karen A Krogfelt
Journal:  Clin Vaccine Immunol       Date:  2011-12-07

5.  Cloning and characterization of a Campylobacter jejuni 72Dz/92 gene encoding a 30 kDa immunopositive protein, component of the ABC transport system; expression of the gene in avirulent Salmonella typhimurium.

Authors:  D Pawelec; E Rozynek; J Popowski; E K Jagusztyn-Krynicka
Journal:  FEMS Immunol Med Microbiol       Date:  1997-10

6.  Immunogenicity and immunoprotection of recombinant PEB1 in Campylobacter-jejuni-infected mice.

Authors:  Lian-Feng Du; Zhen-Jiang Li; Xian-Ying Tang; Jun-Qiong Huang; Wan-Bang Sun
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

Review 7.  Status of vaccine research and development for Campylobacter jejuni.

Authors:  Mark S Riddle; Patricia Guerry
Journal:  Vaccine       Date:  2016-03-11       Impact factor: 3.641

8.  Identification of novel serological biomarkers for inflammatory bowel disease using Escherichia coli proteome chip.

Authors:  Chien-Sheng Chen; Sean Sullivan; Troy Anderson; Aik Choon Tan; Philip J Alex; Steven R Brant; Carmen Cuffari; Theodore M Bayless; Monica V Talor; C Lynne Burek; Huan Wang; Richard Li; Lisa Wu Datta; Yuqiong Wu; Raimond L Winslow; Heng Zhu; Xuhang Li
Journal:  Mol Cell Proteomics       Date:  2009-04-07       Impact factor: 5.911

9.  Identification and characterization of an immunogenic outer membrane protein of Campylobacter jejuni.

Authors:  A Burnens; U Stucki; J Nicolet; J Frey
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

10.  Molecular, antigenic, and functional characteristics of ferric enterobactin receptor CfrA in Campylobacter jejuni.

Authors:  Ximin Zeng; Fuzhou Xu; Jun Lin
Journal:  Infect Immun       Date:  2009-09-08       Impact factor: 3.441

View more
  4 in total

1.  Ehrlichia chaffeensis and E. canis hypothetical protein immunoanalysis reveals small secreted immunodominant proteins and conformation-dependent antibody epitopes.

Authors:  Tian Luo; Jignesh G Patel; Xiaofeng Zhang; David H Walker; Jere W McBride
Journal:  NPJ Vaccines       Date:  2020-09-11       Impact factor: 9.399

2.  Development of a Trivalent Construct Omp18/AhpC/FlgH Multi Epitope Peptide Vaccine Against Campylobacter jejuni.

Authors:  Hongqiang Lou; Xusheng Li; Xiusheng Sheng; Shuiqin Fang; Shaoye Wan; Aihua Sun; Haohao Chen
Journal:  Front Microbiol       Date:  2022-01-13       Impact factor: 5.640

Review 3.  Research progress on detection techniques for point-of-care testing of foodborne pathogens.

Authors:  Sha Liu; Kaixuan Zhao; Meiyuan Huang; Meimei Zeng; Yan Deng; Song Li; Hui Chen; Wen Li; Zhu Chen
Journal:  Front Bioeng Biotechnol       Date:  2022-08-08

4.  Immunoreactive Protein Repertoires of Ehrlichia chaffeensis and E. canis Reveal the Dominance of Hypothetical Proteins and Conformation-Dependent Antibody Epitopes.

Authors:  Tian Luo; Jignesh G Patel; Xiaofeng Zhang; David H Walker; Jere W McBride
Journal:  Infect Immun       Date:  2021-08-02       Impact factor: 3.609

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.